Md. Krasowski et al., TRICHLOROETHANOL MODULATION OF RECOMBINANT GABA(A), GLYCINE AND GABA RHO(1) RECEPTORS, The Journal of pharmacology and experimental therapeutics, 284(3), 1998, pp. 934-942
The actions of 2,2,2,-trichloroethanol were studied on agonist-activat
ed Cl- currents in gamma-aminobutyric acid type A (GABA(A)), glycine a
nd GABA rho(1) receptors by use of the whole-cell patch-clamp techniqu
e. Recombinant wild-type and mutant receptor subunits were transiently
expressed in human embryonic kidney (HEK) 293 cells. Trichloroethanol
enhanced currents elicited by submaximal (EC20) agonist concentration
s at GABA(A) alpha(2) beta(1) receptors and glycine alpha(1) homomeric
receptors in a reversible, concentration-dependent manner. Trichloroe
thanol, at concentrations of less than or equal to 2 mM, did not signi
ficantly alter the magnitude of submaximal GABA currents at GABA rho(1
) receptors, whereas higher concentrations inhibited submaximal GABA c
urrents. Recent work has identified residues within putative transmemb
rane domains 2 and 3 as critical for positive modulation of GABA(A) an
d glycine receptors by n-alkanols and volatile ether anesthetics. Subm
aximal glycine currents at receptors containing either of two specific
mutations within the glycine receptor alpha(1) subunit (S-267\ and A(
288)W) were not enhanced by low concentrations of trichloroethanol and
were inhibited by higher concentrations of trichloroethanol, in the G
ABA(A) alpha(2) beta(1) receptor, a specific mutation within transmemb
rane domain 3 of the beta(1) subunit ((MW)-W-286) also abolished posit
ive modulation by trichloroethanol. Mutations within the GABA(A) alpha
(2) receptor subunit did not alter positive modulation by TCEt, wherea
s such mutations ablate positive modulation by n-alkanols and volatile
anesthetics. In summary, trichloroethanol modulation of GABA(A), glyc
ine and GABA rho(1) receptors shares some, but not all, features in co
mmon with the requirements for modulation by n-alkanols and volatile a
nesthetics.